Product Code: GVR-1-68038-024-8
The global patient engagement solutions market size is expected to reach USD 41.7 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 17.3% over the forecast period. The market is expected to register exponential growth due to the adoption of m-health; increasing prevalence of chronic conditions such as diabetes, asthma, and arthritis; improved healthcare services; enhanced patient education; patient data tracking; and diagnostic treatment.
In July 2019, a bipartisan group in Congress in U.S. introduced a new legislation that would allocate a fund of USD 25 million in grants for local, state, and tribal governments to develop Social Determinants Accelerator Plan with the aim to improve tracking and coordinating patient outcomes. Such initiatives are anticipated to drive the demand for these services over the forecast period.
Moreover, in March 2019, the American Medical Association entered into a collaboration with PatientPoint with the aim to access point of care to help prevent the occurrence of cardiovascular diseases and type 2 diabetes. Using PatientPoint technology, approximately 6,500 practicing doctors across U.S. are expected to educate individuals regarding disease prevention. Programs such as these are expected to drive market growth over the forecast period.
Some of the major market players are Allscripts Healthcare Solutions, Orion Health Ltd., Cerner Corporation, and McKesson Corporation, which collectively account for a substantial market share owing to their extensive product offerings. Moreover, key players are focusing on expanding their portfolio to gain competitive edge over their competitors. For instance, in October 2019, IQVIA launched Orchestrated Patient Engagement, a new cloud-based software as a service (SaaS) solution that narrows the gap between patients and life sciences companies by facilitating insights and interactions.
Further key findings from the study suggest:
Web-based/cloud-based emerged as the largest delivery type segment in 2019 as it supports hassle-free information flow between patients and healthcare providers. Moreover, bulk data can be stored in these platforms and enable remote access
The software segment dominated the market in 2019, owing to continuous development in patient engagement solutions along with its increasing applications in consulting, education, and implementation. Software solutions are easy to install and use, enable quick access to specific drug information, and enable healthcare providers to digitally upload prescriptions
Rising prevalence of chronic diseases such as cardiovascular diseases, obesity, and diabetes, which require constant monitoring, is expected to drive the demand for these services in the coming years
Chronic diseases dominated the market in 2019 owing to the associated benefits of these solutions in chronic disease management. These solutions help patients connect with their healthcare providers from remote locations, thereby enabling streamlined flow of information, patient feedback, and other health-related data
North America dominated the global patient engagement solutions market in 2019 owing to increased adoption of m-health and electronic health record (EHR) and growing investments in patient engagement software by major companies
Companies are adopting various strategies to sustain competition. New product/solution development, partnerships, mergers, acquisitions, strategic collaborations, and geographical penetration are some of the key strategies adopted by market players
Table of Contents
Chapter 1 Research Methodology & Scope
- 1.1 Market Segmentation & Scope
- 1.1.1 Segment Scope
- 1.1.2 Regional Scope
- 1.1.3 Estimates & Forecast Timeline
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased Database:
- 1.3.2 GVR's Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary Research:
- 1.3.5 Details Of Primary Research
- 1.4 Information or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity Flow Analysis (Model 1)
- 1.7 List of Secondary Sources
- 1.8 List of Primary Sources
- 1.9 Abbreviations
- 1.10 Objectives
- 1.10.1 Objective 1
- 1.10.2 Objective 2
- 1.11 Market Definition
Chapter 2 Executive Summary
- 2.1 Market Outlook
- 2.2 Segment Outlook
- 2.3 Competitive Outlook
- 2.4 Patient Engagement Solutions Market Summary, 2019
Chapter 3 Patient Engagement Solutions Market Variables Trends & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Parent Market Outlook
- 3.1.2 Ancillary Market Outlook
- 3.2 Penetration & Growth Prospect Mapping by Technology, 2019
- 3.3 User Perspective Analysis
- 3.3.1 Buyer's Preference Analysis
- 3.3.2 Market Influencer Analysis
- 3.4 Regulatory Framework
- 3.4.1 Regulatory Landscape
- 3.5 Technology Overview
- 3.5.1 Patient engagement solutions: Adoption rate of changing technology
- 3.5.2 Timeline with major technology changes
- 3.6 Market Dynamics
- 3.6.1 Market Driver Analysis
- 3.6.2 Market Restraints Analysis
- 3.6.3 Industry Challenges
- 3.7 Industry Analysis - Porter's
- 3.8 Patient Engagement Solutions - SWOT Analysis, by Factor (Political & Legal, Economic, Social and Technological)
- 3.9 Major Deals & Strategic Alliances Analysis
- 3.9.1 Joint Ventures
- 3.9.2 Mergers & Acquisitions
- 3.9.3 Licensing & Partnership
- 3.9.4 Technology Collaborations
- 3.9.5 Strategic Divestments
- 3.10 Market Entry Strategies
Chapter 4 Patient Engagement Solutions Market: Competitive Analysis
- 4.1 Market Participation Categorization
- 4.2 Vendor Landscape
- 4.2.1 List of key distributors and channel partners
- 4.3 Key company market share analysis, 2019
- 4.4 Public Companies
- 4.4.1 Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
- 4.4.2 Market Differentiators
- 4.4.3 Synergy Analysis: Major Deals & Strategic Alliances
- 4.5 Private Companies
- 4.5.1 List of key emerging companies' /technology disruptors/innovators
- 4.5.2 Regional network map
- 4.6 Key customers
- 4.7 Potential Target Audience
Chapter 5 Patient Engagement Solutions Market: Delivery Type Analysis
- 5.1 Delivery Type Business Analysis
- 5.1.1 Web/Cloud-Based
- 5.1.1.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 5.1.2 On-Premise
- 5.1.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
Chapter 6 Patient Engagement Solutions Market: Component
- 6.1 Component Analysis
- 6.1.1 Software
- 6.1.1.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 6.1.1.2 Standalone
- 6.1.1.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 6.1.1.3 Integrated
- 6.1.1.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 6.1.2 Services
- 6.1.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 6.1.2.2 Consulting Services
- 6.1.2.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 6.1.2.3 Implementation services
- 6.1.2.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 6.1.2.4 Education services
- 6.1.2.4.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 6.1.2.5 Other services
- 6.1.2.5.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 6.1.3 Hardware
- 6.1.3.1 Hardware market estimates and forecasts, 2016 - 2027 (USD Million)
Chapter 7 Patient Engagement Solutions Market: End-Use
- 7.1 End-Use Analysis
- 7.1.1 Payers
- 7.1.1.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 7.1.2 Providers
- 7.1.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 7.1.3 Individual Users
- 7.1.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
Chapter 8 Patient Engagement Solutions Market: Application
- 8.1 Application Analysis
- 8.1.1 Social Management
- 8.1.1.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 8.1.2 Health Management
- 8.1.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 8.1.3 Home Healthcare Management
- 8.1.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 8.1.4 Financial Health Management
- 8.1.4.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
Chapter 9 Patient Engagement Solutions Market: Therapeutic Area
- 9.1 Application Analysis
- 9.1.1 Chronic Diseases
- 9.1.1.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 9.1.1.2 Obesity
- 9.1.1.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 9.1.1.3 Diabetes
- 9.1.1.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 9.1.1.4 Cardiovascular
- 9.1.1.4.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 9.1.1.5 Others
- 9.1.1.5.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 9.1.2 Fitness
- 9.1.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 9.1.3 Women's Health
- 9.1.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 9.1.4 Mental Health
- 9.1.4.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 9.1.5 Others
- 9.1.5.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
Chapter 10 Patient Engagement Solutions: Regional Market Analysis, By Application, Technology, and End Use 2016 - 2027 (USD Million)
- 10.1 Regional Market Share Analysis, 2019 & 2027
- 10.2 Regional Market Dashboard
- 10.3 Regional Market Snapshot
- 10.4 Market Size, & Forecasts and Trend Analysis, 2019 to 2027
- 10.4.1 North America
- 10.4.1.1 Market estimates and segment forecasts, 2016 - 2027 (USD Million)
- 10.4.1.2 U.S.
- 10.4.1.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 10.4.1.3 Canada
- 10.4.1.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 10.4.2 Europe
- 10.4.2.1 Market estimates And Forecasts By Countries, 2016 - 2027 (USD Million)
- 10.4.2.2 U.K.
- 10.4.2.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 10.4.2.3 Germany
- 10.4.2.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 10.4.2.4 France
- 10.4.2.4.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 10.4.2.5 Italy
- 10.4.2.5.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 10.4.2.6 Spain
- 10.4.2.6.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 10.4.2.7 Netherlands
- 10.4.2.7.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 10.4.2.8 Sweden
- 10.4.2.8.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 10.4.3 Asia Pacific
- 10.4.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 10.4.3.2 Japan
- 10.4.3.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 10.4.3.3 China
- 10.4.3.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 10.4.3.4 India
- 10.4.3.4.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 10.5.1 Latin America
- 10.5.1.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 10.5.1.2 Brazil
- 10.5.1.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 10.5.1.3 Mexico
- 10.5.1.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 10.6.1 MEA
- 10.6.1.1 Market estimates and forecasts by countries, 2016 - 2027 (USD Million)
- 10.6.1.2 South Africa
- 10.6.1.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
- 10.6.1.3 Saudi Arabia
- 10.6.1.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
Chapter 11 Company Profiles
- 11.1 Allscripts Healthcare Solutions
- 11.1.1 Company Overview
- 11.1.2 Financial Performance
- 11.1.3 Product Benchmarking
- 11.1.4 Strategic Initiatives
- 11.2 McKesson Corporation
- 11.2.1 Company Overview
- 11.2.2 Financial Performance
- 11.2.3 Product Benchmarking
- 11.2.4 Strategic Initiatives
- 11.3 Orion Health Ltd.
- 11.3.1 Company Overview
- 11.3.2 Financial Performance
- 11.3.3 Product Benchmarking
- 11.3.4 Strategic Initiatives
- 11.4 Cerner Corporation
- 11.4.1 Company Overview
- 11.4.2 Financial Performance
- 11.4.3 Product Benchmarking
- 11.4.4 Strategic Initiatives
- 11.5 Phytel Inc.
- 11.5.1 Company Overview
- 11.5.2 Financial Performance
- 11.5.3 Product Benchmarking
- 11.5.4 Strategic Initiatives
- 11.6 Medecision Inc.
- 11.6.1 Company Overview
- 11.6.2 Financial Performance
- 11.6.3 Product Benchmarking
- 11.6.4 Strategic Initiatives
- 11.7 GetWellNetwork Inc.
- 11.7.1 Company Overview
- 11.7.2 Financial Performance
- 11.7.3 Product Benchmarking
- 11.7.4 Strategic Initiatives
- 11.8 YourCareUniverse Inc.
- 11.8.1 Company Overview
- 11.8.2 Financial Performance
- 11.8.3 Product Benchmarking
- 11.8.4 Strategic Initiatives
- 11.9 Lincor Solutions Ltd.
- 11.9.1 Company Overview
- 11.9.2 Financial Performance
- 11.9.3 Product Benchmarking
- 11.9.4 Strategic Initiatives
- 11.10 Athenahealth, Inc.
- 11.10.1 Company Overview
- 11.10.2 Financial Performance
- 11.10.3 Product Benchmarking
- 11.10.4 Strategic Initiatives
比較リスト
